Market Place
Sourcing Support
VERAXA Biotech Shareholders Approve Merger With Voyager
02 Mar 2026 //
GLOBENEWSWIRE
VERAXA & Voyager File Form F-4 for Proposed Merger
17 Jul 2025 //
GLOBENEWSWIRE
Voyager Adds 4th Alzheimer’s Program Using APOE Approach
16 Jul 2025 //
GLOBENEWSWIRE
Voyager Onboards With U.S. GSA Government-wide OASIS+ Contract
28 May 2025 //
BUSINESSWIRE
Voyager Therapeutics to Present at Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Voyager Therapeutics Announces Q3 2024 Conference Call & Webcast
05 Nov 2024 //
GLOBENEWSWIRE
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Rule
23 Jul 2024 //
GLOBENEWSWIRE
Voyager Therapeutics Announces Inducement Grants Under NASDAQ Rule
09 Jul 2024 //
GLOBENEWSWIRE
Voyager Therapeutics To Present At Multiple Investor Conferences
13 Jun 2024 //
GLOBENEWSWIRE
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
13 May 2024 //
GLOBENEWSWIRE
Voyager Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26 Mar 2024 //
GLOBENEWSWIRE
Voyager Therapeutics Announces Pricing of Public Offering
04 Jan 2024 //
PRESS RELEASE
Voyager Enters Agreement and Strategic Collaboration with Novartis
02 Jan 2024 //
PRESS RELEASE
Voyager asset lands on planet Alexion after Pfizer handoff
06 Nov 2023 //
FIERCE BIOTECH
Will VGX Thrive Despite Crypto Lender’s Bankruptcy, SEC Claims?
21 Jun 2023 //
CCN
Voyager Therapeutics (VYGR) Moves 7.9% Higher: Will This Strength Last?
21 Jun 2023 //
FINANCE YAHOO
Voyager`s Stock`s On An Uptrend: Are Strong Financials Guiding The Market?
25 May 2023 //
FINANCE YAHOO
Voyager Life "now capable of dealing with multinational customers"
24 May 2023 //
FINANCE YAHOO
Voyager Therapeutics Reports First Quarter 2023 Financial and Operating Results
09 May 2023 //
GLOBENEWSWIRE
Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial
07 Mar 2023 //
GLOBENEWSWIRE
Voyager to Receive $25M Payment for License of AAV Capsids
06 Mar 2023 //
GLOBENEWSWIRE
Novartis ready to head for deep space with Voyager
06 Mar 2023 //
FIERCE BIOTECH
New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO & Aspirin
05 Mar 2023 //
PR NEWSWIRE
Voyager Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast
28 Feb 2023 //
GLOBENEWSWIRE
Voyager Therapeutics to Participate in Upcoming Investor Conferences
09 Feb 2023 //
GLOBENEWSWIRE
Voyager Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 Jan 2023 //
GLOBENEWSWIRE
Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors
14 Dec 2022 //
GLOBENEWSWIRE
Voyager Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Nov 2022 //
GLOBENEWSWIRE
Touchlight signs license agreement with Voyager for use of DNA technology
25 Nov 2022 //
PRESS RELEASE
Voyager Therapeutics Reports Third Quarter 2022 Financial and Operating Results
08 Nov 2022 //
GLOBENEWSWIRE
Voyager Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Oct 2022 //
GLOBENEWSWIRE
Voyager Therapeutics Presents Data Characterizing a Novel CNS Receptor
11 Oct 2022 //
GLOBENEWSWIRE
Pfizer pulls trigger on Voyager gene therapy capsid deal
05 Oct 2022 //
FIERCEBIOTECH
Voyager Therapeutics Announces Pfizer License of Next-Generation AAV Capsid
04 Oct 2022 //
GLOBENEWSWIRE
Voyager Announces Data Presentations at the 29th Annual Congress of the ESGCT
03 Oct 2022 //
GLOBENEWSWIRE
Voyager Therapeutics to Participate in Upcoming Investor Conferences
27 Sep 2022 //
GLOBENEWSWIRE
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule
22 Sep 2022 //
GLOBENEWSWIRE
Voyager Therapeutics Appoints Peter Pfreundschuh as CFO
07 Sep 2022 //
GLOBENEWSWIRE
As it rebuilds, Voyager casts clinical sails towards CNS
05 Aug 2022 //
FIERCEBIOTECH
Voyager Therapeutics Reports Second Quarter 2022 Financial and Operating Results
04 Aug 2022 //
GLOBENEWSWIRE
Voyager Presents New Data Demonstrating Novel Candidate Therapeutic Abs
03 Aug 2022 //
GLOBENEWSWIRE
Voyager Therapeutics to Present Second Quarter 2022 Results and Corporate Update
02 Aug 2022 //
GLOBENEWSWIRE
Voyager Tx Appoints Catherine J. Mackey, Ph.D. to its Board of Directors
28 Jul 2022 //
GLOBENEWSWIRE
Voyager`s TRACER Capsids Demonstrate Enhanced CNS Transduction Across Species
19 May 2022 //
GLOBENEWSWIRE
Voyager to Present Preclinical Data from anti-HER2 Antibody Program
16 May 2022 //
GLOBENEWSWIRE
Voyager Therapeutics Reports First Quarter 2022 Financial and Operating Results
04 May 2022 //
GLOBENEWSWIRE
Voyager Therapeutics Announces Multiple Data Presentations at ASGCT
03 May 2022 //
GLOBENEWSWIRE
Sandrock’s first month at Voyager sours as shares crumble on Levin
22 Apr 2022 //
ENDPTS
Voyager Tx Appoints Alfred W. Sandrock, Jr., M.D., Ph.D., as CEO
22 Mar 2022 //
GLOBENEWSWIRE
Novartis and Voyager ink $1.7B gene therapy discovery pact
09 Mar 2022 //
ENDPTS
Voyager Tx Reports Q4 and FY 2021 Financial and Operating Results
08 Mar 2022 //
GLOBENEWSWIRE
Voyager Therapeutics to Participate in Upcoming Investor Conferences
10 Feb 2022 //
GLOBENEWSWIRE
Voyager Therapeutics to Present Preclinical Data from Vectorized Antibody
16 Nov 2021 //
GLOBENEWSWIRE
Pfizer reveals delays across the board for its clinical gene therapy programs
02 Nov 2021 //
ENDPTS
Voyager Presents Positive Preclinical Data Supporting CNS-Directed GBA1
20 Oct 2021 //
GLOBENEWSWIRE
Voyager pens Pfizer gene therapy pact worth $630M
07 Oct 2021 //
FIERCEBIOTECH
Voyager Therapeutics to Participate in Upcoming Investor Conferences
10 Aug 2021 //
GLOBENEWSWIRE
Voyager Therapeutics to Participate in Upcoming Investor Conferences
10 Aug 2021 //
GLOBENEWSWIRE
Voyager Therapeutics’ CEO, R&D chief exit
20 May 2021 //
FIERCEBIOTECH
Voyager Therapeutics Announces Strategic Shift and Leadership Transitions
18 May 2021 //
GLOBENEWSWIRE
